Search research articles
Contact Us
Filters
Showing results (21-30 of 192) with videos related to
Page
of 20
Sort By:
Statistics in Medicine
|
July 12, 2002
Reproducibility probability in clinical trials
Jun Shao, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
July 19, 2005
A hybrid Bayesian adaptive design for dose response trials
Mark Chang, Shein-Chung Chow
Pharmaceuticals (Basel, Switzerland)
|
November 28, 2013
On the regulatory approval pathway of biosimilar products
Jun Wang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 28, 2019
Probability monitoring procedures for sample size determination
Zhipeng Huang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 28, 2019
Demonstrating effectiveness or demonstrating not ineffectiveness - A potential solution for rare disease drug product development?
Shein-Chung Chow, Zhipeng Huang
Therapeutic Innovation & Regulatory Science
|
June 14, 2024
Statistical Analysis for Rating Scale in Clinical Trials
Mengyao Shi, Shein-Chung Chow
Orphanet Journal of Rare Diseases
|
September 22, 2023
Innovative thinking of clinical investigation for rare disease drug development
Peijin Wang, Shein-Chung Chow
Therapeutic Innovation & Regulatory Science
|
April 4, 2026
Power Calculation for Non-inferiority Test Based on Linear Combination of Two Correlated Binary Endpoints
Haojia Song, Shein-Chung Chow
Statistics in Medicine
|
April 15, 2004
Analysis of clinical data with breached blindness
Shein-Chung Chow, Jun Shao
Journal of Biopharmaceutical Statistics
|
November 27, 2002
On statistical power for average bioequivalence testing under replicated crossover designs
Hansheng Wan, Shein-Chung Chow
Page
of 20
Search research articles
Search
Showing results (21-30 of 192) with videos related to
Sort By:
Page
of 20
Statistics in Medicine
|
July 12, 2002
Reproducibility probability in clinical trials
Jun Shao, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
July 19, 2005
A hybrid Bayesian adaptive design for dose response trials
Mark Chang, Shein-Chung Chow
Pharmaceuticals (Basel, Switzerland)
|
November 28, 2013
On the regulatory approval pathway of biosimilar products
Jun Wang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 28, 2019
Probability monitoring procedures for sample size determination
Zhipeng Huang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 28, 2019
Demonstrating effectiveness or demonstrating not ineffectiveness - A potential solution for rare disease drug product development?
Shein-Chung Chow, Zhipeng Huang
Therapeutic Innovation & Regulatory Science
|
June 14, 2024
Statistical Analysis for Rating Scale in Clinical Trials
Mengyao Shi, Shein-Chung Chow
Orphanet Journal of Rare Diseases
|
September 22, 2023
Innovative thinking of clinical investigation for rare disease drug development
Peijin Wang, Shein-Chung Chow
Therapeutic Innovation & Regulatory Science
|
April 4, 2026
Power Calculation for Non-inferiority Test Based on Linear Combination of Two Correlated Binary Endpoints
Haojia Song, Shein-Chung Chow
Statistics in Medicine
|
April 15, 2004
Analysis of clinical data with breached blindness
Shein-Chung Chow, Jun Shao
Journal of Biopharmaceutical Statistics
|
November 27, 2002
On statistical power for average bioequivalence testing under replicated crossover designs
Hansheng Wan, Shein-Chung Chow
Page
of 20